Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
Status:
Completed
Trial end date:
2019-08-23
Target enrollment:
Participant gender:
Summary
This is a 24 week, multicenter, randomized, double-blind, parallel group, placebo-controlled
study to investigate the effects of saxagliptin and sitagliptin on cardiac dimensions and
function in patients with type 2 diabetes (T2DM) mellitus and heart failure (HF).